...of Danaher Corp. have bladder cancer tests based on detection of five mRNAs; and the Exosome Diagnostics Inc....

...company is one of several developing exosome-based programs, including Codiak BioSciences Inc. (Cambridge, Mass.) and Exosome Diagnostics Inc....

...company is one of several developing exosome-based programs, including Codiak BioSciences Inc. (Cambridge, Mass.) and Exosome Diagnostics Inc....

...Research supplier Bio-Techne Corp. (NASDAQ:TECH) will acquire cancer diagnostic company Exosome Diagnostics Inc. (Waltham, Mass.) for $250 million...
...exosomes and is used to predict whether men have high-risk prostate cancer prior to biopsy. Exosome Diagnostics Inc....
...NASDAQ:TECH), Minneapolis, Minn. Business: Diagnostic, Cancer Jaime De Leon ExoDx Prostate(IntelliScore), Prostate cancer liquid biopsy test (exo106) Bio-Techne Corp. Exosome Diagnostics Inc....

...Research supplier Bio-Techne Corp. (NASDAQ:TECH) will acquire cancer diagnostic company Exosome Diagnostics Inc. (Waltham, Mass.) for $250 million...
...off $1.22 to $157.03 on Tuesday. Jaime De Leon ExoDx Prostate(IntelliScore), Prostate cancer liquid biopsy test (exo106) Bio-Techne Corp. Exosome Diagnostics Inc....

...make it available for point-of-care diagnostics. At least six companies are pursuing exosome-based diagnostics, including Exosome Diagnostics Inc....
...exosomes and associated biomarkers from plasma." ACS Nano (2017) Mark Zipkin, Staff Writer Biological Dynamics Inc. Codiak BioSciences Inc. Exosome Diagnostics Inc. University...

...of the cells that shed them. The first exosome-based diagnostic was launched last year by Exosome Diagnostics Inc....
...from his lab identifying GPC1 as a biomarker on exosomes released from pancreatic cancer cells. Exosome Diagnostics...
...A new extracellular vesicle detection system developed at Massachusetts General Hospital has been licensed to Exosome Diagnostics Inc....

...higher than in vesicles from the 8 patients with other abdominal indications. Next steps by Exosome Diagnostics Inc....
...from plasmas for diagnosing pancreatic ductal adenocarcinoma (PDAC) LICENSING STATUS: Patent application filed; licensed to Exosome Diagnostics Inc....
...online May 24, 2017 doi:10.1126/scitranslmed.aal3226 CONTACT: Ralph Weissleder, Massachusetts General Hospital, Boston, Mass. email: rweissleder@mgh.harvard.edu Hongjiang Li Exosome Diagnostics Inc. Massachusetts...

...diagnostic. At least one company already markets a prostate cancer test based on tumor-derived vesicles. Exosome Diagnostics Inc....
...the functional consequence of those changes as they relate to things like metastases,” Lewis said. Exosome Diagnostics...
...John Lewis Patents: None issued Companies and Institutions Mentioned Freenome Inc., South San Francisco, Calif. Exosome Diagnostics Inc....

...patents on the technology are available for licensing and the university is seeking commercial partners. Michael Leviten Exosome Diagnostics University...